LOC493754 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.488600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.829190E-01
Normal-vs-Stage2
2.501400E-01
Normal-vs-Stage3
9.372200E-01
Normal-vs-Stage4
8.209600E-02
Stage1-vs-Stage2
8.693000E-01
Stage1-vs-Stage3
3.916000E-01
Stage1-vs-Stage4
8.103800E-02
Stage2-vs-Stage3
2.362600E-01
Stage2-vs-Stage4
1.438090E-02
Stage3-vs-Stage4
1.014230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.277800E-01
Normal-vs-AfricanAmerican
3.444800E-01
Normal-vs-Asian
6.681400E-01
Caucasian-vs-AfricanAmerican
6.068200E-01
Caucasian-vs-Asian
2.362400E-01
AfricanAmerican-vs-Asian
7.740000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.540600E-01
Normal-vs-Female
2.511800E-01
Male-vs-Female
4.448200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.567220E-01
Normal-vs-Age(41-60Yrs)
5.934400E-02
Normal-vs-Age(61-80Yrs)
4.022000E-01
Normal-vs-Age(81-100Yrs)
1.019170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.255600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.334000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.592800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.216060E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.303800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.763000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.439600E-01
Normal-vs-Daily Drinker
2.452400E-01
Normal-vs-Weekly Drinker
3.416400E-01
Normal-vs-Occasional Drinker
1.678400E-01
Normal-vs-Social Drinker
3.619500E-02
Non Drinker-vs-Daily Drinker
5.941000E-01
Non Drinker-vs-Weekly Drinker
6.244400E-01
Non Drinker-vs-Occasional Drinker
7.828600E-01
Non Drinker-vs-Social Drinker
4.047200E-01
Daily Drinker-vs-Weekly Drinker
9.538600E-01
Daily Drinker-vs-Occasional Drinker
7.912800E-01
Daily Drinker-vs-Social Drinker
8.676600E-01
Weekly Drinker-vs-Occasional Drinker
7.976400E-01
Weekly Drinker-vs-Social Drinker
9.545800E-01
Occasional Drinker-vs-Social Drinker
6.082600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.805760E-01
Normal-vs-Grade 2
2.691500E-02
Normal-vs-Grade 3
3.798400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.903000E-03
Grade 1-vs-Grade 3
9.360700E-03
Grade 1-vs-Grade 4
1.805760E-01
Grade 2-vs-Grade 3
9.531000E-01
Grade 2-vs-Grade 4
2.691500E-02
Grade 3-vs-Grade 4
3.798400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.767400E-01
Normal-vs-NonDiabetic
1.841800E-01
Diabetic-vs-NonDiabetic
5.902000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.435500E-03
Normal-vs-NoPancreatitis
2.875800E-01
Pancreatitis-vs-NoPancreatitis
1.977830E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.879230E-01
Normal-vs-N1
2.771200E-01
N0-vs-N1
5.213800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.797170E-01
Normal-vs-TP53-NonMutant
5.811600E-01
TP53-Mutant-vs-TP53-NonMutant
3.675800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
